Johnson & Johnson Option Alert: Oct 17 $170 Calls at the Ask: 956 vs 12134 OI; Earnings 10/14 Before Open 

Johnson & Johnson Option Alert: Oct 17 $170 Calls at the Ask: 956 @ $9.4 vs 12134 OI; Earnings 10/14 Before Open Ref=$177.405

Johnson & Johnson Option Alert: Oct 17 $155 Calls Sweep (10) near the Ask: 280 vs 724 OI; Earnings 10/14 Before Open 

Johnson & Johnson Option Alert: Oct 17 $155 Calls Sweep (10) near the Ask: 280 @ $21.651 vs 724 OI; Earnings 10/14 Before Open Ref=$175.595

Johnson & Johnson Option Alert: Oct 17 $170 Calls at the Ask: 1000 vs 13137 OI; Earnings 10/14 Before Open 

Johnson & Johnson Option Alert: Oct 17 $170 Calls at the Ask: 1000 @ $7.95 vs 13137 OI; Earnings 10/14 Before Open Ref=$175.3

Johnson & Johnson Option Alert: Nov 21 $190 Calls at the Bid: 3879 vs 1403 OI; Earnings 10/14 Before Open 

Johnson & Johnson Option Alert: Nov 21 $190 Calls at the Bid: 3879 @ $1.51 vs 1403 OI; Earnings 10/14 Before Open Ref=$177.87

Johnson & Johnson Option Alert: Oct 17 $175 Calls Sweep (18) near the Bid: 778 vs 15307 OI; Earnings 10/14 Before Open 

Johnson & Johnson Option Alert: Oct 17 $175 Calls Sweep (18) near the Bid: 778 @ $6.75 vs 15307 OI; Earnings 10/14 Before Open Ref=$178.47

Johnson & Johnson

JOHNSON & JOHNSON

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Press Releases

Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

AMDR Applauds Federal Court Decision to Bar Johnson & Johnson's Biosense Webster Unit from Further Violation of Anti-Trust Laws in a Win for Hospitals, Patients, and the Environment

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump

Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer

Johnson & Johnson to Participate in the Bernstein 2nd Annual Healthcare Forum

Johnson & Johnson Elects John Morikis, Retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company, to its Board of Directors

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Zoetis

Citigroup

Barclays

RBC Capital

Guggenheim

Screenshot 2025-07-10 at 8.34.03 PM

Biotech

News

KERX

When it comes to unmet needs in the nephrology space, acute kidney injury remains a significant concern.

SeaStar Medical&#39;s QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka

Screenshot 2024-09-30 at 9.13.36 PM

General

TNXP

VRTX

The Rush For Non-Addictive Painkillers To Counter The Opioid Crisis Puts Two Companies Closer To FDA Decisions

Screenshot 2024-04-30 at 5.36.02 PM

Health Care

Cardio Diagnostics Holdings Inc. - Common stock

Date	Put/Call	Strike Price	Exp Date	DTE	Trade Vol	Day Vol	Vol / OI	OI	Trade Type	Sentiment
10:13 AMSep 11, 2025	CALL	$170.00	Oct 17, 2025	34	1001	956	8	12134	TRADE	BULLISH
02:26 PMSep 10, 2025	CALL	$155.00	Oct 17, 2025	34	290	280	40	724	SWEEP	BULLISH
09:37 AMSep 10, 2025	CALL	$170.00	Oct 17, 2025	34	1000	1000	8	13137	TRADE	BULLISH
02:10 PMSep 08, 2025	CALL	$190.00	Nov 21, 2025	69	10021	3879	714	1403	TRADE	BEARISH
11:36 AMSep 08, 2025	CALL	$175.00	Oct 17, 2025	34	1057	778	7	15307	SWEEP	BEARISH

Comments

Johnson & Johnson

Unusual Options Activity for

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL